The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
Acute promyelocytic leukemia (APL) has become a highly curable disease after four decades of endeavors. Thanks to the efforts of investigators throughout the world, the chemo-free concept has become a reality for both low- and high-risk patients. All-trans retinoic acid (ATRA) plus arsenic trioxide...
Main Author: | Hong-Hu Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.592996/full |
Similar Items
-
Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study
by: Luana Lenzi, et al.
Published: (2020-12-01) -
Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study
by: Hong-Hu Zhu, et al.
Published: (2021-11-01) -
Treatment for acute promyelocytic leukemia during pregnancy
by: V V Troitskaia, et al.
Published: (2013-10-01) -
Treatment Outcome and the Genetic Characteristics of Acute Promyelocytic Leukemia in Children in Poland From 2005 to 2018
by: Małgorzata Czogała, et al.
Published: (2020-03-01) -
Fournier's Gangrene in a Case of Acute Promyelocytic Leukemia During ATRA Therapy
by: Nasim Valizadeh
Published: (2011-01-01)